Coeptis Therapeutics Holdings, Inc. – NASDAQ:COEPW

Coeptis Therapeutics Holdings stock price today

$0.03
+0.01
+105.48%
Financial Health
0
1
2
3
4
5
6
7
8
9

Coeptis Therapeutics Holdings stock price monthly change

-50.00%
month

Coeptis Therapeutics Holdings stock price quarterly change

-50.00%
quarter

Coeptis Therapeutics Holdings stock price yearly change

-40.71%
year

Coeptis Therapeutics Holdings key metrics

Market Cap
 5.71M
Enterprise value
 N/A
P/E
 N/A
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 N/A
PEG ratio
 N/A
EPS
 -0.56
Revenue
 N/A
EBITDA
 -16.73M
Income
 -16.13M
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Coeptis Therapeutics Holdings stock price history

Coeptis Therapeutics Holdings stock forecast

Coeptis Therapeutics Holdings financial statements

Profit Margin

Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEPW): Profit margin
Jun 2023 0 -3.11M
Sep 2023 0 -6.26M
Dec 2023 1.50M -3.75M -250.06%
Mar 2024 0 -3.00M
COEPW income statement history

Debt to Assets

Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEPW): Debt to assets
Jun 2023 7155699 4.66M 65.21%
Sep 2023 7170767 2.15M 30.11%
Dec 2023 8071089 3.75M 46.55%
Mar 2024 9394321 5.03M 53.6%
COEPW balance sheet history

Cash Flow

Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEPW): Cash Flow
Jun 2023 -1.90M -350K 3.39M
Sep 2023 -1.95M 350K -224.92K
Dec 2023 -1.69M 0 1.75M
Mar 2024 -1.90M -100K 1.56M
COEPW cash flow history

Coeptis Therapeutics Holdings alternative data

Coeptis Therapeutics Holdings
Employees

Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEPW): Employee count
Aug 2023 4
Sep 2023 4
Oct 2023 4
Nov 2023 4
Dec 2023 4
Jan 2024 4
Feb 2024 4
Apr 2024 4
May 2024 4
Jun 2024 4
Jul 2024 4

Coeptis Therapeutics Holdings other data

Frequently Asked Questions (FAQ)

  • What's the price of Coeptis Therapeutics Holdings stock today?

    One share of Coeptis Therapeutics Holdings stock can currently be purchased for approximately $0.03.

  • When is Coeptis Therapeutics Holdings's next earnings date?

    Unfortunately, Coeptis Therapeutics Holdings's (COEPW) next earnings date is currently unknown.

  • Does Coeptis Therapeutics Holdings pay dividends?

    No, Coeptis Therapeutics Holdings does not pay dividends.

  • How much money does Coeptis Therapeutics Holdings make?

    Coeptis Therapeutics Holdings has a market capitalization of 5.71M.

  • What is Coeptis Therapeutics Holdings's stock symbol?

    Coeptis Therapeutics Holdings, Inc. is traded on the NASDAQ under the ticker symbol "COEPW".

  • What is Coeptis Therapeutics Holdings's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Coeptis Therapeutics Holdings?

    Shares of Coeptis Therapeutics Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Coeptis Therapeutics Holdings have?

    As Jul 2024, Coeptis Therapeutics Holdings employs 4 workers.

  • What is Coeptis Therapeutics Holdings's official website?

    The official website for Coeptis Therapeutics Holdings is coeptispharma.com.

  • Where are Coeptis Therapeutics Holdings's headquarters?

    Coeptis Therapeutics Holdings is headquartered at 105 Bradford Road, Wexford, PA.

  • How can i contact Coeptis Therapeutics Holdings?

    Coeptis Therapeutics Holdings's mailing address is 105 Bradford Road, Wexford, PA and company can be reached via phone at +7 249346467.

Coeptis Therapeutics Holdings company profile:

Coeptis Therapeutics Holdings, Inc.

coeptispharma.com
Exchange:

NASDAQ

Full time employees:

4

Industry:

Biotechnology

Sector:

Healthcare

Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops and commercializes generic and branded pharmaceutical products and cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a Vy-Gen drug product for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; and CD38-Diagnostic, an in vitro screening tool to provide the ability to pre-determine which cancer patients are most likely to benefit from targeted anti-CD38 monoclonal antibodies therapies. The company has collaboration with Statera BioPharma to develop and commercialize STAT-201 for Crohn's disease; and Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. Coeptis Therapeutics Holdings, Inc. was founded in 2017 and is headquartered in Wexford, Pennsylvania.

+7 249346467
105 Bradford Road
Wexford, PA 15090

CIK: 0001759186
ISIN: US19207A1161
CUSIP: 19207A116